Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Receives Nasdaq Non-Compliance Notice for Minimum Stockholders' Equity

Analyse IA par Wiseek
Sentiment info
Negatif
Importance info
8
Prix
$1.45
Cap. de marche
$4.769M
Plus bas 52 sem.
$1.25
Plus haut 52 sem.
$19.089
Market data snapshot near publication time

summarizeResume

SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.


check_boxEvenements cles

  • Nasdaq Non-Compliance Notification

    SciSparc Ltd. received a notification from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting approximately $(81,000) as of June 30, 2025.

  • Compliance Plan Deadline

    The company has 45 calendar days, until February 26, 2026, to submit a plan to regain compliance with Nasdaq's listing rules.

  • Expected Resolution

    SciSparc anticipates regaining compliance by December 31, 2025, citing proceeds from a $4.2 million debenture conversion in August 2025 and a registered direct offering in November 2025.


auto_awesomeAnalyse

SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.

Au moment de ce dépôt, SPRC s'échangeait à 1,45 $ sur NASDAQ dans le secteur Life Sciences, pour une capitalisation boursière d'environ 4,8 M $. La fourchette de cours sur 52 semaines allait de 1,25 $ à 19,09 $. Ce dépôt a été évalué avec un sentiment de marché négatif et un score d'importance de 8 sur 10.

descriptionVoir le depot SEC principal

show_chartGraphique des prix

Partager cet article

Copied!

feed SPRC - Dernieres analyses

SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9